Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. Do you suppose I could have another slice of pizza?”Probably won’t happen. His self-professed dedication to Johnnie Walker Red was only exceeded by his passion for excellent pharmaceutical communications.As the cliché goes down at the mood disorders clinic, “Even paranoids have their enemies.” That could describe the relationship of the drugbiz and its bête noire of the moment, Dr. Matthias Rath.The pharma industry has known more than a reasonable share of detractors, demagogues, and dim-bulbs desirous of luncheon invitations on the strength of their righteous opposition to who we are and what we do. In 2000, the EC Court of First Instance ruled manufacturers can reduce bulk supplies of drugs in territories where the penetration of parallel trade is particularly high.There has been success in Canada, too.
Philippe indique 6 postes sur son profil. Covering Canadian and Global Pharmaceutical Economics__________________________________________________________________________________Big Pharmas looking to stymie the operations of Canadian Internet pharmacies and stop cross-border drug sales potentially have several options, but their most effective strategy might be restricting supplies or resorting to demand allocation, according to an industry consultant.“Supply restriction is the most viable strategy here [in Canada],” Nadir Hirji told a Canadian Institute session on cross-border drug sales in Toronto. It would be a stretch, however, to consider such blowhards as enemies. Saying that you’re ensuring Canadian drug supplies with demand planning goes over a lot better than actually saying pharmacy X&Y has been blacklisted.”But restricting supplies is not a free and open road, because it can result in sideways purchasing. Discreet Packing. • A highly productive researcher with 48 publications (24 as first authors) since 2011. In-depth coverage of Pharma, Biotech, Regulatory, Clinical Trials, Deals and M&A, Financing, Drugs, Cell &; Gene Therapy and more. Edelman has won AstraZeneca's entire oncology portfolio, including Casodex and Zoladex. The deal, which could be worth up to an additional $17 million, will allow Juvisé to sell the drug in more than 50 countries, including Germany, France, and Switzerland. You don’t have to promote it.”The Pharmaceutical Advertising Advisory Board is part of the regulatory process, and Commish Ray Chepesiuk reports it rejects many off-label claims because the PAAB process is a pre-clearance review.PAAB will accept only evidence from prospective, randomized trials that have been published in peer-reviewed publications. Market Realist specializes in must-know news highlights, in-depth analysis, and overviews of companies as well as industries. Among the speakers were: Vancouver GP and author Dr. Gabor Maté, and Canadian painter Robert Bateman, along with Dr. Richard Satava, a US military surgeon who spoke chillingly of his research which combines biology and technology, and Achilla Orru, a sightless African musician whose haunting voice lifted attendees spirits.Astrophysicists shared podium space with self-described sexual activists. )Basically, it explains the circumstances where Health Canada will deem a particular piece as promotional or not. AstraZeneca PLC is a Swedish-British multinational pharmaceutical and biopharmaceutical company with its global headquarters in Cambridge, England.
Obviously, Mao was just joshing in the second part. “You cannot trade in parallel imports in most of Europe unless you get a licence. But it is not illegal in some circumstances to provide information about any prospective benefits of off-label use.“What has to be understood is that the Food and Drugs Act applies to advertising,” says Ann Sztuke-Fournier, manager of the regulatory advertising and risk communications section of Health Canada.“It does not apply to messages that are deemed informational or to the exchange of scientific information.”Given this interpretation, any event considered educational where “truly scientific information” is disseminated is not regulated by the Food and Drugs Act, she adds.